INTEGER INVESTMENTS

  • HOME

  • INVESTMENTS

    • INVESTMENT BELIEFS
    • INVESTMENT AREAS
  • TECHNOLOGY & SECURITY

  • TEAM

  • PERFORMANCE

    • PERFORMANCE
    • RISKS
    • FEES
  • RESEARCH

  • TOOLS

  • SUBSCRIBE

  • More

    Use tab to navigate through the menu items.
    Nike - A Secondary Market Analysis
    Jim (Jiecheng) Huang
    • Oct 19, 2017
    • 1 min

    Nike - A Secondary Market Analysis

    - Jordan brand has fallen from the resell market and it is hurting Nike. - Nike is still the top apparel brand after all. - Valuation model shows a fair value of $47. To read the full article click here. #Nike
    Which Apparel/Footwear Company Should You Invest In?
    Jim (Jiecheng) Huang
    • Aug 10, 2017
    • 1 min

    Which Apparel/Footwear Company Should You Invest In?

    - We compared companies such as Nike, Adidas, Lululemon, Under Armour and Skechers. - Growth opportunities exist within China, huge potentials for Lululemon and Skechers. - Skechers is our top pick. To read the full article click here. #stockmarket #FootLocker #Nike #underarmour #adidas #Skechers #lululemon
    Foot Locker and Nike
    Cristiano Bellavitis, Ph.D.
    • Jun 21, 2017
    • 1 min

    Foot Locker and Nike

    - Shares of sport retailers are down significantly on speculation that Nike is going to sell directly on Amazon. - However, Nike is already on Amazon. - Even if this news was accurate, the negative impact on revenues should be minimal. To read the full article click here. #stockmarket #FootLocker #Nike
    Is Now The Time To Buy Nike?
    Hamish Kumar
    • Jun 8, 2017
    • 1 min

    Is Now The Time To Buy Nike?

    -Nike operates as a designer, manufacturer and retailer of athletic footwear, apparel, equipment and accessories. - The company’s recent Q3 2017 results has demonstrated solid growth, with sales growing by 5% compared to Q3 2016. - Here we discuss the robust qualitative factors that are driving Nike’s growth, before providing a valuation on the business. To read the full article click here. #Nike
    Drug Distributors Revisited
    Cristiano Bellavitis, Ph.D.
    • Jun 5, 2017
    • 1 min

    Drug Distributors Revisited

    - At the end of 2016, political claims sent pharma stocks into a tailspin. - We recommended starting positions and ABC and MCK performed well, while CAH lagged. - Today we re-analyze the three stocks. To read the full article click here. #TEGNA #TGNA #Stocks #stockmarket #Deere #IBM #Akorn #CVS #Nike
    Integer Investments: An Update On Our Portfolio (And How We Protect Against Market Risks)
    Integer Investments
    • Feb 27, 2017
    • 1 min

    Integer Investments: An Update On Our Portfolio (And How We Protect Against Market Risks)

    - Our portfolio performed very well in 2016 (26% ROC, 44.9% ROI) and we believe that we are well positioned for this year. - We are cautious on market risks and valuations. - We discuss our hedging strategy as well as our new investments. To read the full article click here. #TEGNA #TGNA #Stocks #stockmarket #Deere #IBM #Akorn #CVS #Nike
    Nike: Should You Wait For A 'Fire Sale' Price?
    Integer Investments
    • Jan 2, 2017
    • 1 min

    Nike: Should You Wait For A 'Fire Sale' Price?

    - Nike is superb company. - Over the last year, Nike’s share price has declined 19%. - It is now fairly valued and offers the opportunity to start a position.. To read the full article click here. #Nike